Director at Acadia Healthcare (ACHC) receives 6,331-share stock grant

Rhea-AI Filing Summary

Gregg Vicky B reported acquisition or exercise transactions in this Form 4 filing.

Acadia Healthcare Company, Inc. director Vicky B. Gregg reported receiving a stock award of 6,331 shares of common stock on May 6, 2026. The grant was at no cash cost per share and increased her direct holdings to 42,628 shares after the transaction. According to the filing, these awarded shares will vest over three years in equal yearly installments beginning May 6, 2027, meaning portions of the grant become available gradually rather than all at once.

Insider Trade Summary

Net Buyer: 6,331 shares

Net Buy 1 txn

Insider Gregg Vicky B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,331	$0.00	$0.00

Holdings After Transaction: Common Stock — 42,628 shares (Direct)

Footnotes (1)

1. F1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

Key Figures

Stock award: 6,331 shares Holdings after grant: 42,628 shares Grant price: $0.00 per share +2 more

5 metrics

Stock award 6,331 shares Common Stock grant to director on May 6, 2026

Holdings after grant 42,628 shares Director’s direct ownership following the transaction

Grant price $0.00 per share Reported transaction price on Form 4

Vesting period 3 years Award vests in equal yearly installments

Vesting start date May 6, 2027 First installment vesting date for awarded shares

Key Terms

Grant, award, or other acquisition, Common Stock, vest over a 3-year period

3 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

vest over a 3-year period financial

"Shares will vest over a 3-year period in equal yearly installments"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/08/2026 - 05:01 PM Learn about SEC filing dates

FAQ

What insider transaction did Acadia Healthcare (ACHC) report for Vicky B. Gregg?

Acadia Healthcare reported that director Vicky B. Gregg received a stock award of 6,331 shares of common stock. The grant was recorded at no cash cost per share and represents compensation rather than an open-market purchase or sale.

How many Acadia Healthcare (ACHC) shares does Vicky B. Gregg hold after this Form 4?

After the reported stock award, Vicky B. Gregg directly holds 42,628 shares of Acadia Healthcare common stock. This total reflects her position immediately following the 6,331-share grant described in the Form 4 filing.

How do the newly granted Acadia Healthcare (ACHC) shares vest for Vicky B. Gregg?

The 6,331-share award to Vicky B. Gregg vests over three years in equal yearly installments. Vesting begins on May 6, 2027, so the shares become available gradually, aligning compensation with ongoing board service over that period.

Was Vicky B. Gregg’s Acadia Healthcare (ACHC) transaction a market buy or sell?

The transaction was not a market buy or sell. It was classified as a grant or award acquisition, coded “A” on the Form 4, meaning the shares were issued as compensation rather than purchased or sold in the open market.

What does transaction code “A” mean in the Acadia Healthcare (ACHC) Form 4?

Transaction code “A” on the Form 4 indicates a grant, award, or other acquisition of shares. For Vicky B. Gregg, it reflects a stock award of 6,331 Acadia Healthcare common shares received as compensation, with no cash price per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gregg Vicky B

(Last) (First) (Middle)

4020 ASPEN GROVE DRIVE, SUITE 900

(Street)

FRANKLIN TENNESSEE 37067

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Acadia Healthcare Company, Inc. [ ACHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/06/2026		A		6,331(1)	A	$0.0	42,628	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.

	/s/ Brian Farley as Attorney in Fact for Vicky B. Gregg	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)